Parametric Portfolio Associates’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $139K | Buy |
28,068
+8,056
| +40% | +$39.9K | ﹤0.01% | 3511 |
|
|
2021
Q4 | $139K | Buy |
20,012
+4,212
| +27% | +$29.3K | ﹤0.01% | 3501 |
|
|
2021
Q3 | $158K | Sell |
15,800
-2,541
| -14% | -$25.4K | ﹤0.01% | 3477 |
|
|
2021
Q2 | $260K | Buy |
18,341
+2,376
| +15% | +$33.7K | ﹤0.01% | 3307 |
|
|
2021
Q1 | $262K | Sell |
15,965
-82,126
| -84% | -$1.35M | ﹤0.01% | 3769 |
|
|
2020
Q4 | $2.03M | Buy |
98,091
+84,789
| +637% | +$1.75M | ﹤0.01% | 2639 |
|
|
2020
Q3 | $101K | Sell |
13,302
-5,495
| -29% | -$41.7K | ﹤0.01% | 3794 |
|
|
2020
Q2 | $157K | Buy |
18,797
+6,034
| +47% | +$50.4K | ﹤0.01% | 3692 |
|
|
2020
Q1 | $63K | Buy |
12,763
+1,229
| +11% | +$6.07K | ﹤0.01% | 3804 |
|
|
2019
Q4 | $46K | Sell |
11,534
-2,983
| -21% | -$11.9K | ﹤0.01% | 3927 |
|
|
2019
Q3 | $44K | Buy |
14,517
+2,259
| +18% | +$6.85K | ﹤0.01% | 3904 |
|
|
2019
Q2 | $54K | Sell |
12,258
-9,891
| -45% | -$43.6K | ﹤0.01% | 3904 |
|
|
2019
Q1 | $88K | Buy |
22,149
+994
| +5% | +$3.95K | ﹤0.01% | 3832 |
|
|
2018
Q4 | $84K | Sell |
21,155
-32,613
| -61% | -$129K | ﹤0.01% | 3802 |
|
|
2018
Q3 | $370K | Sell |
53,768
-3,057
| -5% | -$21K | ﹤0.01% | 3548 |
|
|
2018
Q2 | $384K | Sell |
56,825
-4,649
| -8% | -$31.4K | ﹤0.01% | 3454 |
|
|
2018
Q1 | $400K | Buy |
61,474
+24,576
| +67% | +$160K | ﹤0.01% | 3448 |
|
|
2017
Q4 | $164K | Sell |
36,898
-13,321
| -27% | -$59.2K | ﹤0.01% | 3782 |
|
|
2017
Q3 | $310K | Sell |
50,219
-10,300
| -17% | -$63.6K | ﹤0.01% | 3661 |
|
|
2017
Q2 | $561K | Buy |
60,519
+29,937
| +98% | +$278K | ﹤0.01% | 3297 |
|
|
2017
Q1 | $284K | Buy |
30,582
+401
| +1% | +$3.72K | ﹤0.01% | 3449 |
|
|
2016
Q4 | $253K | Buy |
+30,181
| New | +$253K | ﹤0.01% | 3503 |
|